Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02794597 · ClinicalTrials.gov registry record · NA
Improving Reproductive Health for Women in Opioid Medication-Assisted Treatment (OMAT)
A NA study of Contraception, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
- 1
- Study location
NCT02794597: Completed NA study of Contraception, sponsored by Denver Health and Hospital Authority.
NCT02794597 is a NA study of Contraception that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 119 participants, below the 453-participant average among 72 other Contraception trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02794597, a NA study of Contraception, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
- 1
- Study location
Study Summary
Recent research suggests that women with substance use disorders may be at a higher risk of unintended pregnancy. There is a paucity of interventions specifically focused on this population. Through using mixed methods, this study proposes to develop a brief peer-led intervention (based on the Health Belief Model) to prevent unintended pregnancies among women entering opioid medication-assisted treatment; to assess acceptability, feasibility and the initial efficacy of the behavioral intervention; and to conduct exploratory analyses to identify the Health Belief Model constructs that are most influential on use of long-acting reversible contraception methods. Future research would include testing the intervention in a larger scale trial and with other populations.
Primary Outcome
Assess initial efficacy (family planning/clinical visits and uptake of birth control, specifically long-acting reversible contraceptives (LARCs) of the SHINE intervention, using baseline/follow up surveys and review of medical records at three and six months. Specifically, the number of participants that were using LARCs and the number of participants who had attended family visits at each time point.
Conditions Studied
Interventions
- BEHAVIORAL SHINE intervention group
Study Locations (1)
Colorado
- Denver Health and Hospital Authority - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-08 |
| Phase | NA |
What the finished NCT02794597 record still lists
NCT02794597 is an interventional study that assigns participants to a tested intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 453-participant average among 72 other Contraception trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which SHINE intervention group is the first listed.
NCT02794597 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02794597 about?
NCT02794597 is a clinical study titled "Improving Reproductive Health for Women in Opioid Medication-Assisted Treatment (OMAT)". Recent research suggests that women with substance use disorders may be at a higher risk of unintended pregnancy. There is a paucity of interventions specifically focused on this population. Through using mixed methods, this study proposes to develop a brief peer-led intervention (based on the Healt...
What is the current status of trial NCT02794597?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2016-08. Estimated completion is 2019-08.
What conditions does trial NCT02794597 study?
This clinical trial studies the following conditions: Contraception.
What interventions are being tested in trial NCT02794597?
The interventions under investigation include: SHINE intervention group (BEHAVIORAL).
Who is sponsoring clinical trial NCT02794597?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02794597 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02794597's enrollment target sits among peer trials
119 41st of 72 higher than 31 of 72 other Contraception trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
-
Contraceptive Efficacy Study of Ovaprene
RECRUITING · NA
-
Intervening on Women's Health for Rural Young Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia